Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines, Boosters & 3rd Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts


Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

Evan Mark Braunstein, M.D., Ph.D.

Headshot of Evan Mark Braunstein
  • Assistant Professor of Medicine


Anemias, Hematology, Leukopenia, Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders, Thrombocytopenias more


The Johns Hopkins Hospital

600 N. Wolfe Street
Blalock Building, Suite 266
Baltimore, MD 21287 map

The Johns Hopkins Hospital

600 N. Wolfe Street
Ross Building, Room 1016A
Baltimore, MD 21287 map
Fax: 410-955-0185


Dr. Evan M. Braunstein is an Assistant Professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include inherited hematologic malignancies, myeloproliferative neoplasms myelodysplastic syndromes, clonal hematopoiesis of indeterminate potential, cytopenias and hematology.

Dr. Braunstein earned his M.D. and Ph.D. at Yeshiva University’s Albert Einstein College of Medicine. He completed his residency in internal medicine at Mount Sinai Medical Center in New York. He performed a fellowship in hematology at Johns Hopkins. more


  • Assistant Professor of Medicine
  • Assistant Professor of Oncology

Departments / Divisions



  • MD; Albert Einstein College of Medicine (2009)


  • Internal Medicine; The Mount Sinai Hospital (2011)


  • Oncology; Johns Hopkins University School of Medicine (2015)

Board Certifications

  • American Board of Internal Medicine (Hematology) (2016)
  • American Board of Internal Medicine (Internal Medicine) (2015)

Research & Publications

Research Summary

Dr. Braunstein's research focuses on inherited predisposition to hematologic diseases. His laboratory studies the inherited genetic changes in DNA that increase susceptibility to disease. Blood cancers such as myeloproliferative neoplasms and myelodysplastic syndromes are traditionally thought to be acquired disorders, however there is increasing evidence that inherited genetic changes play a role. In addition, Dr. Braunstein studies blood disorders such as atypical hemolytic uremic syndrome which are caused in part by genetic mutations.  

Is this you? Edit Profile
back to top button